Companies: 10,795·Total market cap: $144.5T
Vaxcyte, Inc.

Vaxcyte, Inc.

PCVXNASDAQHealthcare● Active
$45.93
$-1.43(-3.02%)
Market Cap$6.6B
P/E Ratio
52W High$65
52W Low$29.08
Overview

Vaxcyte, Inc.(PCVX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

pcvx · 股价预测 · 11 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 11 位华尔街分析师

SellBuy

Buy

11 位分析师

共识

评级分布

Strong Buy
0
Buy
11
Hold
0
Sell
0
Strong Sell
0
合计: 11 · 买入占比: 100.0%

12 个月目标价

High

$89.00

Consensus

$89.00

+94.8% upside

Low

$89.00

Median: $89 · Last Close: $45.69

Vaxcyte, Inc.(PCVX)的分析师共识为 Buy,基于过去 3 个月内 11 位华尔街分析师的评级。PCVX 的 12 个月平均目标价为 $89.00,相对当前价 $45.69 代表 +94.8% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$44.093.50%

1-day model range: $43.81–$44.37. Peak: $44.37 (-3.50%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$79+72.4%
2028$113+147.3%
2029$142+211.8%
2030$165+260.6%
2031+294.4%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)41.3Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · PCVX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$47.23SELL
MA 10$48.86SELL
MA 20$49.80SELL
MA 50$55.22SELL
MA 100$55.40SELL
MA 200$48.35SELL
Current $PCVX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$47.32SELL
EMA 10$48.27SELL
EMA 20$49.99SELL
EMA 50$52.94SELL
EMA 100$52.86SELL
EMA 200$48.49SELL
Current $PCVX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
BTIG2026-02-26
Maintains
BuyBuy
Guggenheim2026-02-02
Maintains
BuyBuy
BTIG2025-11-10
Maintains
BuyBuy
BTIG2025-10-16
Maintains
BuyBuy
Needham2025-04-08
Maintains
BuyBuy
Needham2025-04-01
Maintains
BuyBuy
B of A Securities2025-04-01
Maintains
BuyBuy
Goldman Sachs2025-04-01
Maintains
BuyBuy
Guggenheim2025-03-12
Maintains
BuyBuy
Needham2025-02-26
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Vaxcyte, Inc. (PCVX) stock. Of the recent 45 rating actions, 0 were upgrades and 0 were downgrades. 11 analysts currently cover PCVX.

分析师推荐趋势

Buy ratings422
Hold ratings00
Sell ratings00

PCVX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 2 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$25M

↓ 85.9% YoY

Revenue Next Year

$87M

↑ 248.6% YoY

EPS This Year

$-8.13

EPS Next Year

$-6.67

↓ 18.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast PCVX EPS of $-8.13 for the current fiscal year, based on estimates from 6 analysts. The PCVX revenue forecast is $25M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

PCVX 股价预测由两类独立数据源支撑:来自 11 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。PCVX 的共识目标价为 $89.00(+94.8% 上行空间),分析师共识为 Buy。

PCVX 的短期预测(明日)为 $44.09(-3.50%)。 PCVX 对 2027 年的股价预测均值为 $79。 PCVX 对 2030 年的预测区间为 $153–$176。

Vaxcyte, Inc. 在 NASDAQ 上市,代码 PCVX。PCVX 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

PCVX 预测 · 8 个问题

根据 11 位华尔街分析师,PCVX 的 12 个月平均目标价为 $89.00,最高 $89.00、最低 $89.00。若有图表,中位目标价可在上方查看。相对当前价 $45.69,隐含约 +94.8% 的上行空间。

PCVX 目标价PCVX 分析师目标价PCVX 12个月目标价目标价 PCVX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.